학술논문

Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group
Document Type
Article
Source
In: Journal of the European Academy of Dermatology and Venereology. (Journal of the European Academy of Dermatology and Venereology, December 2023, 37(12):2517-2525)
Subject
Language
English
ISSN
14683083
09269959